Welcome to Nanomedicine

For researchers in the know!

Read editorials detailing cutting edge developments in the field of nanomedicine and see if there are any up and coming conferences you would like to attend.  Explore possible careers within the nanomedicine community or put your research on our map and read information about regulatory authorities ensuring right steps are being taken within your research.

read more

Are You New To Nanomedicine?

Information about nanomedicine for people without background knowledge in science is provided.  Provides an introduction to nanomedicine, an overview of the nanomedicines currently in clinical use, a glossary of sciencitifc terms often used in nanomedicine and a section on frequently asked questions.

read more

Everything teachers and pupils need to know about Nanomedicine

Fun and simple classroom activities are available for teaching and learning about the key principles of nanotechnology as well as short videos to help with explanations.  Up to date nanonews and brief explanations of current research involving nanomedicine are also available.

read more

Welcome to the British Society for Nanomedicine

With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK

European Nanomedicine Meeting, ENM2015

Joint Meeting with the French Society for Nanomedicine

The British Society of Nanomedicine (BSNM) is proud to be working with colleagues at Société Française de Nanomédecine (SFNano) to organise the first European Nanomedicine Meeting, ENM2015. The meeting will be held between the 7th and 9th of December 2015 in the beautiful city of Grenoble, in South Eastern France. Speakers include leading academic and industrial nanomedicine researchers from across Europe and the programme integrates sessions on Nanocarriers for Macromolecule Delivery, Nano and Micro-Medical Devices, Nanomedicine for Tissue Regeneration, Nano-specific Toxicological issues, Nanomedicines and Imaging, and Nanomedicines in Cancer. Abstracts submission closes on the 15th October 2015 but registration remains open thereafter. For further details, to submit abstracts or to register, please visit www.sfnano.fr/enm-2015. 

For further details please look here

Journal of Interdisciplinary Nanomedicine

Editors-in-Chief Steve Rannard, Raj Bawa, Si-Shen Feng and Andrew Owen

The Journal of Interdisciplinary Nanomedicine (JOIN) is an international peer-reviewed academic journal that aims to provide truly interdisciplinary nanomedicine research. JOIN is now accepting submissions from all relevant fields to be included in the first issue

The journal contains evidence-based research and translational outputs with high-level contributions from at least two sciences that are peer-reviewed by multiple reviewers tasked to focus primarily on their specialist areas. Multiple first and/or corresponding author status is encouraged so as to provide transparency and acknowledgment for contribution to multidisciplinary work. The Journal embraces submissions from all relevant fields as applied to early stage scientific developments and studies aimed at the progression of nanomedicines towards the clinic, which include engineering, science and medicine, especially materials sciences, life science, clinical science, intellectual property, regulatory issues and policy considerations. JOIN contains original research papers, editorials, review articles, technical notes, and letters to the editor about matters that may benefit the wider readership. Advances that are progressing to application through consolidation of multiple areas of expertise are especially encouraged. Core areas of particular interest include applications of new materials and biological concepts, targeted delivery, molecular biomaterials and nanotechnology in diagnostics, pharmacology, pharmaceutics, toxicology, and clinical outcomes.

For further details please look here

Targeting Siglecs with a sialic acid–decorated nanoparticle abrogates inflammation

Sepsis is a dreaded diagnosis; clinicians have few tools to fight this generalized inflammatory response to infection that too often results in death. Spence et al have recently pubblished an article in "Science Translational Medicine" where they demonstrate that the sialic acid–decorated nanoparticle boosts this anti-inflammatory response in culture, and also show that it improves survival in two mouse models of generalized sepsis and one of pulmonary injury. Most encouraging for the ultimate utility of this nanoparticle in human patients, the nanoparticle is effective in human macrophages and in a sophisticated ex vivo model of human lung edema.

For further details please look here